Global Benign Prostatic Hyperplasia Devices Market By Type (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Surgery, Prostatic Stenting, Others), By Application (Hospitals and Clinics, Ambulatory Surgical Centers(ASC), Home, Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 134928
- 16-Dec
- PDF/PPT/Word
-
Report Details
The report on Global Benign Prostatic Hyperplasia Devices Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The Global benign prostatic hyperplasia devices Market is segmented on the basis of Type, Application, and geography.
The Global Benign Prostatic Hyperplasia Devices Market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.Benign Prostatic Hyperplasia Devices Market Scope:
By type, the market is segmented into Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Surgery, Prostatic Stenting, and Others. By Application, the market is divided into Hospitals and Clinics, Ambulatory Surgical Centers(ASC), Home, and Others.
Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Lumenis, Olympus corporation, Urologix, Boston Scientific corporation, Lisa Laser, Medifocus, Neotrac, ProArc Medical LTD, and Urotech GMBH.Key Market Segments
Type
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
OthersApplication
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
OthersKey Market Players included in the report:
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBHReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Benign Prostatic Hyperplasia Devices Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Benign Prostatic Hyperplasia Devices Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Global Benign Prostatic Hyperplasia Devices Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the Global Benign Prostatic Hyperplasia Devices Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Global Benign Prostatic Hyperplasia Devices Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Global Benign Prostatic Hyperplasia Devices Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Global Benign Prostatic Hyperplasia Devices Market sub-markets, depending on key regions (various vital states).
To analyze Global Benign Prostatic Hyperplasia Devices Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Global Benign Prostatic Hyperplasia Devices Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
Primary worldwide Global Benign Prostatic Hyperplasia Devices Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Global Benign Prostatic Hyperplasia Devices Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Benign Prostatic Hyperplasia Devices Market Overview3.1. Global Benign Prostatic Hyperplasia Devices Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Benign Prostatic Hyperplasia Devices Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Benign Prostatic Hyperplasia Devices Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Transurethral Resection of the Prostate (TURP)
4.4. Transurethral Microwave Therapy (TUMT)
4.5. Transurethral Needle Ablation of the Prostate (TUNA)
4.6. Laser Surgery
4.7. Prostatic Stenting
4.8. Others5. Global Benign Prostatic Hyperplasia Devices Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Benign Prostatic Hyperplasia Devices Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Hospitals and Clinics
5.4. Ambulatory Surgical Centers(ASC)
5.5. Home
5.6. Others6. Global Benign Prostatic Hyperplasia Devices Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
6.1.1. 1.US
6.1.1. 2.Canada
6.1.1. 3.Mexico6.2. Europe
6.2.1. Europe Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4.India
6.3.1.5.Rest of Asia6.4. Latin America
6.4.1. Latin America Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Benign Prostatic Hyperplasia Devices Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Lumenis7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Olympus corporation7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Urologix7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Boston Scientific corporation7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Lisa Laser7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Medifocus7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Neotrac7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. ProArc Medical LTD7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Urotech GMBH7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample